In this article, Seahee Kim discusses how CDMOs are expediting drug development using approaches such as a single cell line platform approach and standardised upstream/downstream process (USP/DSP) methodologies.

Join our webinar with Altasciences to learn the key advantages and differences of conducting early phase clinical trials in North America versus other geographic regions.

The European Medicines Agency (EMA)’s human medicines agency (CHMP) begins a rolling review of Valneva’s COVID-19 vaccine VLA2001 following positive preliminary results.

The Medicines and Healthcare products Regulatory Agency (MHRA) approve sotrovimab for people with mild to moderate COVID-19 infection and at least one risk factor for developing severe illness.

Sanofi has entered into an agreement to acquire Origimm Biotechnology to add a potential first-in-class vaccine for acne to their pipeline.